Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Shum

Showing results (141-150 of 168) with videos related to

Pageof 17
Sort By:
Antiviral Research|August 28, 2018
High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle systemNakyung Lee, David Shum, Alexander König, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 28, 2010
Do patients with schizophrenia and healthy elderly people show similar patterns of prospective memory performance?Ya Wang, Raymond C K Chan, Yong-hong Qing, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 3, 2026
MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2Jinyeong Heo, Soonju Park, Honggun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V Angeles, Ana Velez, Jordan Rios, et al.
Viruses|April 30, 2021
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19Meehyun Ko, So Young Chang, Soo Young Byun, et al.
Immune Network|September 15, 2021
Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 VaccinesJi Yeun Kim, Seongman Bae, Soonju Park, et al.
International Journal of Molecular Sciences|January 11, 2024
Madurastatins with Imidazolidinone Rings: Natural Products or Side-Reaction Products from Extraction Solvents?Mercedes Pérez-Bonilla, Marina Sánchez-Hidalgo, Ignacio González, et al.
The Journal of Infectious Diseases|December 1, 2021
Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month PeriodJi Yeun Kim, So Yun Lim, Soonju Park, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2022
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screeningDiego Benítez, Jaime Franco, Florencia Sardi, et al.
Toxins|July 2, 2021
Anti-Cancer Effect of Moroccan Cobra <i>Naja haje</i> Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell CultureAyoub Lafnoune, Su-Yeon Lee, Jin-Yeong Heo, et al.
Pageof 17

Showing results (141-150 of 168) with videos related to

Sort By:
Pageof 17
Antiviral Research|August 28, 2018
High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle systemNakyung Lee, David Shum, Alexander König, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 28, 2010
Do patients with schizophrenia and healthy elderly people show similar patterns of prospective memory performance?Ya Wang, Raymond C K Chan, Yong-hong Qing, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 3, 2026
MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2Jinyeong Heo, Soonju Park, Honggun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated LiposarcomaChristina V Angeles, Ana Velez, Jordan Rios, et al.
Viruses|April 30, 2021
Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19Meehyun Ko, So Young Chang, Soo Young Byun, et al.
Immune Network|September 15, 2021
Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 VaccinesJi Yeun Kim, Seongman Bae, Soonju Park, et al.
International Journal of Molecular Sciences|January 11, 2024
Madurastatins with Imidazolidinone Rings: Natural Products or Side-Reaction Products from Extraction Solvents?Mercedes Pérez-Bonilla, Marina Sánchez-Hidalgo, Ignacio González, et al.
The Journal of Infectious Diseases|December 1, 2021
Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month PeriodJi Yeun Kim, So Yun Lim, Soonju Park, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2022
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screeningDiego Benítez, Jaime Franco, Florencia Sardi, et al.
Toxins|July 2, 2021
Anti-Cancer Effect of Moroccan Cobra <i>Naja haje</i> Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell CultureAyoub Lafnoune, Su-Yeon Lee, Jin-Yeong Heo, et al.
Pageof 17